CELLDEX THERAPEUTICS, INC.

Profile

Company Names

CELLDEX THERAPEUTICS, INC.

Addresses

53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ 08827

Phone Numbers

908-200-7500

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$62,500,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2016-11-29 
$62,500,000.00 
$62,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AVERY 
W. 
CATLIN 
EXECUTIVE OFFICER
CELLDEX THERAPEUTICS, INC.   |  CELLDEX THERAPEUTICS, INC.
HERBERT 
J. 
CONRAD 
DIRECTOR
CELLDEX THERAPEUTICS, INC.   |  CELLDEX THERAPEUTICS, INC.
LARRY 
 
ELLBERGER 
DIRECTOR
CELLDEX THERAPEUTICS, INC.   |  CELLDEX THERAPEUTICS, INC.
GEORGE 
O. 
ELSTON 
DIRECTOR
CELLDEX THERAPEUTICS, INC.   |  CELLDEX THERAPEUTICS, INC.   |  EYEPOINT PHARMACEUTICALS, INC.
ANTHONY 
S. 
MARUCCI 
EXECUTIVE OFFICER, DIRECTOR
CELLDEX THERAPEUTICS, INC.   |  CELLDEX THERAPEUTICS, INC.
HARRY 
H. 
PENNER, JR. 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  RIB X PHARMACEUTICALS INC   |  RIB-X PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  NEW HAVEN PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.
KAREN 
 
SHOOS 
DIRECTOR
CELLDEX THERAPEUTICS, INC.   |  CELLDEX THERAPEUTICS, INC.
RICHARD 
 
VAN DEN BROEK 
DIRECTOR
REFLEXION PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.   |  PULSE BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-11-29
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2016-11-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#